MDA Space Ltd. MDA
—
31.49
0.01
0.03%
as of 25 Sep
- Market cap
- $5.2B
- P/E
- 53.6×
Follow MDA
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
70.23 | 41.68 | 49.29 | 49.29 |
+3 more quarters Free account |
P/S ratio |
4.24 | 2.57 | 3.27 | 3.27 | |
P/FCF ratio |
0.00 | 0.00 | 40.42 | 40.42 | |
P/Operating CF |
(84.45) | 73.22 | 107.21 | 107.21 | |
P/B ratio |
4.20 | 2.41 | 3.95 | 3.95 | |
Price to Tangible BV |
38.67 | 26.37 | 0.00 | 0.00 | |
EV/Sales |
4.22 | 2.47 | 3.42 | 3.42 | |
EV/EBITDA |
24.76 | 13.89 | 19.59 | 19.59 | |
EV/Operating CF |
154.33 | 20.76 | 13.71 | 13.71 | |
EV/FCF |
(32.64) | (45.47) | 42.22 | 42.22 | |
Quick Ratio |
0.69 | 0.73 | 0.41 | 0.49 | |
Current Ratio |
0.75 | 0.80 | 0.47 | 0.55 | |
Net Debt/EBITDA |
(0.51) | (2.22) | 2.75 | 2.92 | |
Debt/Assets |
9.54% | 9.51% | 11.65% | 11.81% | |
Debt/Equity |
0.19 | 0.20 | 0.29 | 0.31 | |
Asset Turnover |
0.54 | 0.53 | 0.54 | — | |
Operating CF/Net income |
(3.37) | 2.06 | 2.06 | 1.40 | |
Capex/Depreciation |
(1.40) | (2.08) | (1.74) | (1.72) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
2.61% | 1.85% | 2.93% | 2.90% | |
Selling, General and Administrative Expense of Revenue |
10.37% | 7.76% | 7.06% | 8.08% | |
Intangible Assets out of Total Assets |
0.45 | 0.44 | 0.50 | 0.48 | |
Share Based Compensation of Revenue |
1.10% | 0.93% | 0.67% | 0.98% | |
Graham Net Nets |
(0.12) | (0.20) | (0.26) | (0.26) | |
Graham Number |
11.41 | 11.97 | 10.48 | 0.00 | |
Earnings Yield |
1.42% | 2.40% | 2.03% | 2.03% | |
Free Cash Flow Yield |
(3.05%) | (2.11%) | 2.47% | 2.47% | |
Revenue per Share |
2.59 | 2.64 | 2.87 | 2.37 | |
Operating CF per Share |
(0.49) | 0.35 | 0.29 | 0.20 | |
Capex per Share |
(0.33) | (0.50) | (0.41) | (0.41) | |
Free Cash Flow per Share |
(0.81) | (0.16) | (0.12) | (0.21) | |
Cash per Share |
2.07 | 3.09 | 0.88 | 1.13 | |
Shareholders Equity per Share |
9.84 | 10.49 | 7.81 | 7.69 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
9.84 | 10.49 | 7.81 | 7.69 | |
Free Cash Flow |
(113.00) | (20.12) | (15.50) | (26.09) | |
Working Capital |
(222.47) | (195.35) | (503.35) | (461.16) | |
Capital Expenditures |
(45.14) | (64.51) | (51.20) | (50.83) | |
Net Current Asset Value |
(685.75) | (662.64) | (992.46) | (987.95) | |
EV/EBIT |
52.73 | 26.51 | 35.40 | 35.40 | |
Capex to Sales |
0.13 | 0.19 | 0.14 | 0.17 | |
Net Profit Margin |
5.60% | 6.38% | 4.86% | 5.95% | |
Price to Operating Income |
52.99 | 27.64 | 33.88 | 33.88 | |
| Other line items | |||||
Average Receivables |
297.90 | 286.66 | 276.68 | — | |
Average Payables |
309.72 | 265.99 | 230.81 | — | |
Average Inventory |
16.47 | 17.80 | 11.37 | — | |
Average Assets |
2,501.56 | 2,376.21 | 2,148.84 | — | |
Average Common Equity |
1,146.34 | 1,096.16 | 914.01 | — |
Columns are period end dates